| PARION SCIENCES, Inc. Patent applications |
| Patent application number | Title | Published |
|---|
| 20120116083 | HETEROAROMATIC PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS - Polyaromatic sodium channel blockers represented by the formula: | 05-10-2012 |
| 20110195973 | CYCLIC SUBSTITUTED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS POSSESSING BETA AGONIST ACTIVITY - The present invention relates to sodium channel blockers. The present Invention also includes a variety of methods of treatment using these inventive sodium channel blockers. | 08-11-2011 |
| 20110144338 | METHODS OF REDUCING RISK OF INFECTION FROM PATHOGENS - Prophylactic treatment methods are provided for protection of individuals and/or populations against infection from airborne pathogens. In particular, prophylactic treatment methods are provided comprising administering a sodium channel blocker or pharmaceutically acceptable salts thereof to one or more members of a population at risk of exposure to or already exposed to one or more airborne pathogens, either from natural sources or from intentional release of pathogens into the environment. | 06-16-2011 |
| 20110046158 | CAPPED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS - The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. | 02-24-2011 |
| 20110008268 | PHENYL SUBSTITUTED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS POSSESSING BETA AGONIST ACTIVITY - The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. | 01-13-2011 |
| 20110003832 | NEW CAPPED Pyrazinoylguanidine SODIUM CHANNEL BLOCKERS - The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. | 01-06-2011 |
| 20100267746 | ALIPHATIC PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS WITH BETA AGONIST ACTIVITY - The present invention provides sodium channel blockers possessing beta-adrenergic receptor agonist activity. | 10-21-2010 |
| 20100144661 | SODIUM CHANNEL BLOCKERS - The present invention relates to sodium channel blockers. The present invention also relates to a variety of methods of treatment using the sodium channel blockers. | 06-10-2010 |
| 20100074881 | MULTIPLE NEBULIZER SYSTEMS - A device for administering two or more therapeutic agents simultaneously, comprising two or more nebulizers and a single connector linking the nebulizers to a nebulizer mouthpiece. Also provided is a method of administering two or more therapeutic agents simultaneously, comprising administering the therapeutic agents simultaneously with the device of the present invention to a subject in need thereof. | 03-25-2010 |
| 20090324724 | SOLUBLE AMIDE & ESTER PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS - The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. | 12-31-2009 |
| 20090214444 | POLY AROMATIC SODIUM CHANNEL BLOCKERS - Polyaromatic sodium channel blockers represented by the formula: | 08-27-2009 |
| 20090104272 | INHALED HYPERTONIC SALINE DELIVERED BY A HEATED NASAL CANNULA - The invention described herein is directed to method of treating chronic obstructive pulmonary disease, comprising administering an effective amount of an osmolyte by at least one nasal cannula to a subject in need thereof. Also provided is a nasal cannula system for delivering an osmolyte, comprising a nebulizer and tubing having two ends, where the first end of the tubing is connected to the nebulizer and the second end of the tubing is tapered to fit in the nostril of a subject. | 04-23-2009 |
| 20090082287 | METHODS OF ENHANCING MUCOSAL HYDRATION AND MUCOSAL CLEARANCE BY TREATMENT WITH SODIUM CHANNEL BLOCKERS AND OSMOLYTES - The present invention relates to methods and compositions for treating diseases ameliorated by increased mucociliary clearance and mucosal hydration by administering an effective amount of a sodium channel blocker as defined herein and an osmolyte to a subject to a subject in need of increased mucociliary clearance and mucosal hydration. | 03-26-2009 |
| 20090076273 | SOLUBLE AMIDE & ESTER PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS - The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. | 03-19-2009 |
| 20090062308 | METHODS OF USING SODIUM CHANNEL BLOCKERS - The present invention relates to use of a compound represented by formula (I): | 03-05-2009 |
| 20090018144 | CAPPED PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS - The present invention relates to compounds represented by formula (I): | 01-15-2009 |
| 20080293740 | METHOD OF TREATING ACID-SENSING ION CHANNEL MEDIATED PAIN, COUGH SUPPRESSION, AND CENTRAL NERVOUS SYSTEM DISORDERS - The present invention provides a variety of methods of treatment of acid-sensing ion channel (ASIC) mediated pain, cough, and central nervous system disorders by ASICs inhibition with a series of pyrazinoylguanidine compounds represented by formula (I) as defined herein. | 11-27-2008 |
| 20080249109 | PYRAZINOYLGUANIDINE COMPOUNDS FOR USE AS TASTE MODULATORS - The present invention relates to blocking salt taste using compounds of Formula I as defined herein. | 10-09-2008 |
| 20080200476 | ALAPHATIC PYRAZINOYLGUANIDINE SODIUM CHANNEL BLOCKERS - The present invention relates to sodium channel blockers. The present invention also includes a variety of methods of treatment using these inventive sodium channel blockers. | 08-21-2008 |
